Response to ‘Treatment of fibromuscular dysplasia’
نویسندگان
چکیده
منابع مشابه
Treatment of renal artery fibromuscular dysplasia.
Fibromuscular dysplasia is a nonatherosclerotic and noninflammatory disease that can result in stenoses of the renal arteries and hypertension, most commonly affecting middle-aged women. Percutaneous transluminal angioplasty has long been considered the mainstay of therapy and offers high rates of improved or cured hypertension. The disease involves the mid and distal renal arteries and branchp...
متن کاملFibromuscular Dysplasia.
The most common clinical manifestations of fibromuscular dysplasia (FMD) are hypertension due to renal artery involvement and transient ischemic attack or stroke due to carotid or vertebral artery involvement. Patients with renal artery FMD and hypertension should undergo primary angioplasty with the goal of curing the hypertension. If the blood pressure fails to normalize following angioplasty...
متن کاملFibromuscular dysplasia
Fibromuscular dysplasia (FMD), formerly called fibromuscular fibroplasia, is a group of nonatherosclerotic, noninflammatory arterial diseases that most commonly involve the renal and carotid arteries. The prevalence of symptomatic renal artery FMD is about 4/1000 and the prevalence of cervicocranial FMD is probably half that. Histological classification discriminates three main subtypes, intima...
متن کاملFibromuscular Dysplasia
The circulatory system is made up of the heart and blood vessels. There are 3 major types of blood vessels: arteries, veins, and lymphatics. The heart is the pumping organ and helps to push oxygenand nutrient-rich blood through the arteries to the organs and the limbs. The veins return blood from the organs and limbs to the heart so that it can be resupplied with oxygen from the lungs. The lymp...
متن کاملInvasive treatment for carotid fibromuscular dysplasia
INTRODUCTION Fibromuscular dysplasia (FMD) is an infrequent non-inflamatory disease of unknown etiology that affects mainly medium-size arteries. The prevalence of FMD among patients scheduled for endovascular treatment of carotid artery stenosis is unknown. AIM To evaluate the prevalence and treatment options of carotid FMD in patients scheduled for carotid artery stenting (CAS). MATERIAL ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 2008
ISSN: 0085-2538
DOI: 10.1038/ki.2008.174